Systemic fungal infections: major problems in cancer patients.
- 1 September 1994
- journal article
- review article
- Vol. 31 (3) , 180-4
Abstract
Over the last decade, with increasing use of aggressive chemotherapy and bone marrow transplantation in the treatment of cancer, fungi have emerged as a major pathogen. The prognosis of established systemic fungal infections remains poor, but newer antifungal drugs such as fluconazole are changing the outlook of therapy and prophylaxis considerably.This publication has 0 references indexed in Scilit: